KRAs (Colorectal Cancer Marker) Mutations in Mumbai

KRAS (COLORECTAL CANCER MARKER) MUTATIONS panel is a diagnostic test that helps in detecting mutations in the KRAS gene. The KRAS gene is responsible for producing a protein that regulates the normal growth of cells. However, when a mutation occurs in this gene, it can lead to uncontrolled cell growth, which may result in the development of colorectal cancer. This test is designed to identify these mutations and aid in the diagnosis and treatment of colorectal cancer.

Symptoms of Colorectal Cancer

Colorectal cancer often develops without any noticeable symptoms in its early stages. However, as the cancer progresses, some common symptoms may arise. These include:

1. Rectal bleeding or blood in stools
2. Persistent abdominal discomforts such as cramps, gas or pain
3. A persistent feeling of needing to pass stools despite having just had a bowel movement
4. Unexplained weight loss
5. Weakness or fatigue

Test Procedure

The KRAs (Colorectal Cancer Marker) Mutations Panel requires a PARAFFIN BLOCK sample. The sample required for this test is usually obtained from a biopsy or a surgical specimen from a colorectal cancer patient. The tissue sample is then sent to the laboratory for analysis.

The laboratory technicians extract and sequence the DNA from the tissue sample to look for any mutations in the KRAS gene. The test results are reported in terms of the presence or absence of mutations in the KRAS gene. The KRAs (Colorectal Cancer Marker) Mutations Panel uses advanced molecular diagnostic techniques to analyse the tissue sample for mutations in the KRAS gene. The test results are usually available within 16 days after the tissue sample is received by the laboratory.

Treatment for Colorectal Cancer

If a patient is diagnosed with colorectal cancer, treatment options depend on the stage of cancer and its location. Treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy. If the test results are positive for KRAS mutations, it is important to consult your doctor immediately. Your doctor will work with you to develop a personalized treatment plan based on your unique needs and medical history.

Booking a Test Slot on Apollo 24|7

To book a KRAs (Colorectal Cancer Marker) Mutations Panel test on Apollo 24|7, visit the website and select the test from the list of available tests. Follow the instructions to book a slot for sample collection at your preferred time and location. Once you have booked your appointment, you will receive a confirmation email with all the details. The test report will be available within 16 days of sample collection.

Benefits of Early Diagnosis

Early diagnosis of colorectal cancer increases the chances of successful treatment and recovery. By detecting mutations in the KRAS gene early on, this panel can help identify individuals who may be at risk of developing colorectal cancer before symptoms appear. Early diagnosis can also reduce the need for extensive treatment and may improve survival rates. Additionally, early diagnosis can help reduce the risk of complications and improve overall quality of life.